Introduction:
Qilian International Holdings Group Co., Ltd. is a Cayman exempt company, which was incorporated on February 7, 2019. The company currently governs Qilian International (Hong Kong) Holdings Co., Ltd., Qilian International Trade (Chengdu) Co., Ltd., Gansu Qilianshan Pharmaceutical Co., Ltd., Chengdu Qilianshan Biotechnology Co., Ltd., Jiuquan Qiming Biotechnology Co., Ltd., and Jiuquan Ahan Biotechnology Co., Ltd. Scientific Co., Ltd., Tibet Cangmen Trade Co., Ltd., etc., mainly research and development, production and sales of antibiotic raw materials, compound licorice lozenges and other solid preparations, Chinese medicine extracts, crude heparin sodium, sausage casings, bio-organic fertilizer, antibacterial (antibacterial) Products, consumer products, etc., engaged in the research and development of biological sciences and biological products, medical technology research, biological product research and development, with "Qilian Mountain", "Gandixin", "Moshang" medical technology research and development, self-produced products and Domestic and foreign trade of various APIs, intermediates, Chinese medicinal materials, chemical products, organic fertilizers, veterinary APIs and technologies. "Fa", "Zhuxiaochang" and other well-known domestic brands, of which "Moshangfa" is a brand on the CCTV list.